Exact Mass: 1310.6083874

Exact Mass Matches: 1310.6083874

Found 8 metabolites which its exact mass value is equals to given mass value 1310.6083874, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Triptorelin

[D-Trp6]-LH-RH

C64H82N18O13 (1310.6308442)


L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02A - Hormones and related agents > L02AE - Gonadotropin releasing hormone analogues C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1910 - Gonadotropin-releasing Hormone Analog D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents D012102 - Reproductive Control Agents > D008186 - Luteolytic Agents D000970 - Antineoplastic Agents

   

(D-Ser4,D-Trp6)-LHRH

N-(1-{2-[(carbamoylmethyl)carbamoyl]pyrrolidin-1-yl}-5-[(diaminomethylidene)amino]-1-oxopentan-2-yl)-2-{2-[2-(3-hydroxy-2-{2-[3-(1H-imidazol-5-yl)-2-[(5-oxopyrrolidin-2-yl)formamido]propanamido]-3-(1H-indol-3-yl)propanamido}propanamido)-3-(4-hydroxyphenyl)propanamido]-3-(1H-indol-3-yl)propanamido}-4-methylpentanamide

C64H82N18O13 (1310.6308442)


   
   

3-O-beta-D-galactopyranosyl(1->2)-beta-D-glucuronopyranosyl-21-O-[3-(3-benzoyloxy-2-methylbutyryl)-4-benzoyl-alpha-L-arabinopyranosyl]-22-O-acetylbarringtogenol C

3-O-beta-D-galactopyranosyl(1->2)-beta-D-glucuronopyranosyl-21-O-[3-(3-benzoyloxy-2-methylbutyryl)-4-benzoyl-alpha-L-arabinopyranosyl]-22-O-acetylbarringtogenol C

C68H94O25 (1310.6083874)


   

3beta,6alpha,20xi-trihydroxy-23-oxo-5alpha-cholest-9(11)-en-6alpha-yl O-beta-D-fucopyranosyl-(1->3)-O-beta-D-fucopyranosyl-(1->2)-O-beta-D-galactopyranosyl-(1->4)-O-2)>-O-beta-D-xylopyranosyl-(1->3)-O-beta-D-quinovopyranoside|3beta,6alpha,20xi-trihydroxy-23-oxo-5alpha-cholest-9(11)-en-6alpha-yl O-beta-D-fucopyranosyl-(1->3)-O-beta-D-fucopyranosyl-(1->2)-O-beta-D-galactopyranosyl-(1->4)-O-[beta-D-quinovopyranosyl-(1->2)]-O-beta-D-xylopyranosyl-(1->3)-O-beta-D-quinovopyranoside

3beta,6alpha,20xi-trihydroxy-23-oxo-5alpha-cholest-9(11)-en-6alpha-yl O-beta-D-fucopyranosyl-(1->3)-O-beta-D-fucopyranosyl-(1->2)-O-beta-D-galactopyranosyl-(1->4)-O-2)>-O-beta-D-xylopyranosyl-(1->3)-O-beta-D-quinovopyranoside|3beta,6alpha,20xi-trihydroxy-23-oxo-5alpha-cholest-9(11)-en-6alpha-yl O-beta-D-fucopyranosyl-(1->3)-O-beta-D-fucopyranosyl-(1->2)-O-beta-D-galactopyranosyl-(1->4)-O-[beta-D-quinovopyranosyl-(1->2)]-O-beta-D-xylopyranosyl-(1->3)-O-beta-D-quinovopyranoside

C62H102O29 (1310.6506442)


   
   

(D-His2,D-Trp6)-LHRH

(D-His2,D-Trp6)-LHRH

C64H82N18O13 (1310.6308442)


(D-His2,D-Trp6)-LHRH ((D-His2)-Triptorelin) is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development[1].

   

(2s,3s,4s,5r,6r)-6-{[(3s,4s,4ar,6ar,6bs,8ar,9s,10r,12as,14ar,14br)-10-(acetyloxy)-9-{[(2s,3r,4s,5s)-3,5-dihydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-5-{[(2s,3r,4s,5r,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxyoxane-2-carboxylic acid

(2s,3s,4s,5r,6r)-6-{[(3s,4s,4ar,6ar,6bs,8ar,9s,10r,12as,14ar,14br)-10-(acetyloxy)-9-{[(2s,3r,4s,5s)-3,5-dihydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-4-(hydroxymethyl)-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-5-{[(2s,3r,4s,5r,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxyoxane-2-carboxylic acid

C61H98O30 (1310.6142608)